List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Influenza Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Influenza Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Market by Application
1.3.1 Global Influenza Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Influenza Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Influenza Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Influenza Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Influenza Vaccine Sales by Region
2.4.1 Global Influenza Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Influenza Vaccine by Region (2023-2028)
2.5 Global Influenza Vaccine Revenue by Region
2.5.1 Global Influenza Vaccine Revenue by Region (2017-2022)
2.5.2 Global Influenza Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Influenza Vaccine Sales by Manufacturers
3.1.1 Global Top Influenza Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Influenza Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Influenza Vaccine in 2021
3.2 Global Influenza Vaccine Revenue by Manufacturers
3.2.1 Global Influenza Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Influenza Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Influenza Vaccine Revenue in 2021
3.3 Global Influenza Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Influenza Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Influenza Vaccine Sales by Type
4.1.1 Global Influenza Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Influenza Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Influenza Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Influenza Vaccine Revenue by Type
4.2.1 Global Influenza Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Influenza Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Influenza Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Influenza Vaccine Price by Type
4.3.1 Global Influenza Vaccine Price by Type (2017-2022)
4.3.2 Global Influenza Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Influenza Vaccine Sales by Application
5.1.1 Global Influenza Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Influenza Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Influenza Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Influenza Vaccine Revenue by Application
5.2.1 Global Influenza Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Influenza Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Influenza Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Influenza Vaccine Price by Application
5.3.1 Global Influenza Vaccine Price by Application (2017-2022)
5.3.2 Global Influenza Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Influenza Vaccine Market Size by Type
6.1.1 North America Influenza Vaccine Sales by Type (2017-2028)
6.1.2 North America Influenza Vaccine Revenue by Type (2017-2028)
6.2 North America Influenza Vaccine Market Size by Application
6.2.1 North America Influenza Vaccine Sales by Application (2017-2028)
6.2.2 North America Influenza Vaccine Revenue by Application (2017-2028)
6.3 North America Influenza Vaccine Market Size by Country
6.3.1 North America Influenza Vaccine Sales by Country (2017-2028)
6.3.2 North America Influenza Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Influenza Vaccine Market Size by Type
7.1.1 Europe Influenza Vaccine Sales by Type (2017-2028)
7.1.2 Europe Influenza Vaccine Revenue by Type (2017-2028)
7.2 Europe Influenza Vaccine Market Size by Application
7.2.1 Europe Influenza Vaccine Sales by Application (2017-2028)
7.2.2 Europe Influenza Vaccine Revenue by Application (2017-2028)
7.3 Europe Influenza Vaccine Market Size by Country
7.3.1 Europe Influenza Vaccine Sales by Country (2017-2028)
7.3.2 Europe Influenza Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Influenza Vaccine Market Size by Type
8.1.1 Asia Pacific Influenza Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Influenza Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Influenza Vaccine Market Size by Application
8.2.1 Asia Pacific Influenza Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Influenza Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Influenza Vaccine Market Size by Region
8.3.1 Asia Pacific Influenza Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Influenza Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Influenza Vaccine Market Size by Type
9.1.1 Latin America Influenza Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Influenza Vaccine Revenue by Type (2017-2028)
9.2 Latin America Influenza Vaccine Market Size by Application
9.2.1 Latin America Influenza Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Influenza Vaccine Revenue by Application (2017-2028)
9.3 Latin America Influenza Vaccine Market Size by Country
9.3.1 Latin America Influenza Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Influenza Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Influenza Vaccine Market Size by Type
10.1.1 Middle East and Africa Influenza Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Influenza Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Influenza Vaccine Market Size by Application
10.2.1 Middle East and Africa Influenza Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Influenza Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Influenza Vaccine Market Size by Country
10.3.1 Middle East and Africa Influenza Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Influenza Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 CSL
11.1.1 CSL Corporation Information
11.1.2 CSL Overview
11.1.3 CSL Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 CSL Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CSL Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GSK Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Sanofi Pasteur
11.3.1 Sanofi Pasteur Corporation Information
11.3.2 Sanofi Pasteur Overview
11.3.3 Sanofi Pasteur Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi Pasteur Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Pasteur Recent Developments
11.4 Mylan
11.4.1 Mylan Corporation Information
11.4.2 Mylan Overview
11.4.3 Mylan Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Mylan Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Recent Developments
11.5 Hulan Bio
11.5.1 Hulan Bio Corporation Information
11.5.2 Hulan Bio Overview
11.5.3 Hulan Bio Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Hulan Bio Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Hulan Bio Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Corporation Information
11.6.2 AstraZeneca Overview
11.6.3 AstraZeneca Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 AstraZeneca Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 AstraZeneca Recent Developments
11.7 CCBIO
11.7.1 CCBIO Corporation Information
11.7.2 CCBIO Overview
11.7.3 CCBIO Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 CCBIO Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 CCBIO Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Influenza Vaccine Industry Chain Analysis
12.2 Influenza Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Influenza Vaccine Production Mode & Process
12.4 Influenza Vaccine Sales and Marketing
12.4.1 Influenza Vaccine Sales Channels
12.4.2 Influenza Vaccine Distributors
12.5 Influenza Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Influenza Vaccine Industry Trends
13.2 Influenza Vaccine Market Drivers
13.3 Influenza Vaccine Market Challenges
13.4 Influenza Vaccine Market Restraints
14 Key Findings in The Global Influenza Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
